Explore comprehensive CDMO services offered by Great Bay Bio, supporting end-to-end Drug Development and Manufacturing. Great Bay Bio enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: Great Bay Bio (GBB) is a Hong Kong-based high-tech biopharmaceutical company using AI, big data, and IoT to accelerate drug development, reduce costs, and solve industry challenges like long timelines and high failure rates, with platforms like AlfaMedX for cell media and Klone4.0 for cell line development, supporting global R&D and aiming to improve human health through innovation.
